Click here to see an annotated bibliography of the data in the table.
This is a table of authors, titles, dates and other bibliographic information; it is a list metadata describing the content of your study carrel. Think of it as your library.
| id | author | title | date | words | sentences | text |
|---|---|---|---|---|---|---|
| cord-317739-2wojtboi | Abo, Stéphanie M.C. | Modelling the daily risk of ebola in the presence and absence of a potential vaccine | 2020-10-15 | nan | nan | view text |
| cord-005400-50lmj4op | Ada, Gordon | Overview of vaccines and vaccination | 2005 | 7479.0 | 386.0 | view text |
| cord-023853-y5g4ceq9 | Affolder, Rebecca | Global Immunization Challenge: Progress and Opportunities | 2009-05-18 | nan | nan | view text |
| cord-297203-f3f31h4r | Afrough, B. | Emerging viruses and current strategies for vaccine intervention | 2019-04-16 | nan | nan | view text |
| cord-258624-041cf99j | Ahmad, Sajjad | Design of a Novel Multi Epitope-Based Vaccine for Pandemic Coronavirus Disease (COVID-19) by Vaccinomics and Probable Prevention Strategy against Avenging Zoonotics | 2020-05-23 | 8187.0 | 434.0 | view text |
| cord-355541-5sctqkwr | Alcamí, José | Current situation in the development of a preventive HIV vaccine | 2005-07-31 | nan | nan | view text |
| cord-335948-qkfxfmxb | Ampofo, William K. | Improving influenza vaccine virus selectionReport of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14–16 June 2010 | 2011-08-08 | 10006.0 | 401.0 | view text |
| cord-344006-0iq9s94n | Atzrodt, Cassandra L. | A Guide to COVID‐19: a global pandemic caused by the novel coronavirus SARS‐CoV‐2 | 2020-05-23 | nan | nan | view text |
| cord-163946-a4vtc7rp | Awasthi, Raghav | VacSIM: Learning Effective Strategies for COVID-19 Vaccine Distribution using Reinforcement Learning | 2020-09-14 | 4475.0 | 251.0 | view text |
| cord-307899-427a7i3h | BITTLE, JAMES L. | Vaccines Produced by Conventional Means to Control Major Infectious Diseases of Man and Animals | 1989-12-31 | 17476.0 | 1073.0 | view text |
| cord-271528-ob4l0bcf | Bar-Zeev, Naor | COVID-19 vaccines: early success and remaining challenges | 2020-09-04 | 1498.0 | 87.0 | view text |
| cord-314009-7t1bzc7f | Barclay, T. | Vaccine Adjuvant Nanotechnologies | 2016-10-07 | 7652.0 | 403.0 | view text |
| cord-340994-m7vazpq9 | Barello, Serena | ‘Vaccine hesitancy’ among university students in Italy during the COVID-19 pandemic | 2020-08-06 | 1708.0 | 78.0 | view text |
| cord-018265-twp33bb6 | Becker, Pablo D. | Community-acquired pneumonia: paving the way towards new vaccination concepts | 2007 | 14121.0 | 697.0 | view text |
| cord-022349-z8w1wkm8 | Beeler, Judy A. | Human and Animal Viruses | 2007-09-02 | nan | nan | view text |
| cord-345191-nabxpyw3 | Bell, Sadie | Parents’ and guardians’ views on the acceptability of a future COVID-19 vaccine: a multi-methods study in England | 2020-10-19 | nan | nan | view text |
| cord-296839-b6bm8do1 | Bernasconi, Valentina | Developing vaccines against epidemic-prone emerging infectious diseases | 2019-11-27 | nan | nan | view text |
| cord-287067-rrsgl377 | Beutels, Philippe | Funding of drugs: do vaccines warrant a different approach? | 2008-11-30 | nan | nan | view text |
| cord-018497-oy7hsrpt | Beutels, Philippe P.A. | Economic aspects of vaccines and vaccination: a global perspective | 2005 | nan | nan | view text |
| cord-318272-spt0oea0 | Bhardwaj, Prateek | Advancements in prophylactic and therapeutic nanovaccines | 2020-04-05 | 14561.0 | 732.0 | view text |
| cord-264571-rtac6hh2 | Bhatia, Saurabh | Chapter 9 Edible Vaccines | 2015-12-31 | nan | nan | view text |
| cord-266202-3qku90ml | Billington, John | Developing Vaccines for SARS-CoV-2 and Future Epidemics and Pandemics: Applying Lessons from Past Outbreaks | 2020-06-01 | nan | nan | view text |
| cord-269448-1jikrn37 | Borja-Cabrera, G.P. | Immunogenicity assay of the Leishmune(®) vaccine against canine visceral leishmaniasis in Brazil | 2008-09-15 | 4941.0 | 231.0 | view text |
| cord-344062-8xxu0orq | Bozkurt, Hayrunnisa Bekis | Is the impact of childhood vaccines on coronavirus disease 2019, which is moderate in pediatric patients, possible? | 2020-07-31 | 151.0 | 20.0 | view text |
| cord-324219-z1nigtb5 | Bradbury, Jane | Custom-made vaccines at speed | 2003-06-15 | 977.0 | 54.0 | view text |
| cord-294366-swwz4kzd | Bramwell, Vincent W. | The rational design of vaccines | 2005-11-15 | 4880.0 | 200.0 | view text |
| cord-001260-6krujv2m | Bremer, Paul T. | Injection Route and TLR9 Agonist Addition Significantly Impact Heroin Vaccine Efficacy | 2014-02-11 | 3612.0 | 206.0 | view text |
| cord-315339-dcui85lw | Broadbent, Andrew J. | Respiratory Virus Vaccines | 2015-03-13 | 28246.0 | 1270.0 | view text |
| cord-003806-ctass7hz | Bull, James J. | Recombinant vector vaccine evolution | 2019-07-19 | nan | nan | view text |
| cord-004518-jd1wxobz | Běláková, Jana | DNA vaccines: are they still just a powerful tool for the future? | 2007-12-03 | 8107.0 | 409.0 | view text |
| cord-273526-ah0dvnxv | Cao, Weiping | Nasal delivery of Protollin-adjuvanted H5N1 vaccine induces enhanced systemic as well as mucosal immunity in mice | 2017-06-05 | 4390.0 | 222.0 | view text |
| cord-299315-s43gw24k | Capps, Benjamin | One Health, Vaccines and Ebola: The Opportunities for Shared Benefits | 2015-09-16 | 10082.0 | 485.0 | view text |
| cord-324829-0nz0qioh | Carabineiro, Sónia Alexandra Correia | Applications of Gold Nanoparticles in Nanomedicine: Recent Advances in Vaccines † | 2017-05-22 | nan | nan | view text |
| cord-275033-y9z9l0ji | Carter-Pokras, O. | The Role of Epidemiology in Informing United States Childhood Immunization Policy and Practice | 2020-10-14 | 8531.0 | 504.0 | view text |
| cord-287824-zg5akivn | Chan, Yinghan | Advanced drug delivery systems can assist in managing influenza virus infection: A hypothesis | 2020-09-24 | 1158.0 | 84.0 | view text |
| cord-266259-0f0guyea | Chandler, Rebecca E. | Optimizing safety surveillance for COVID-19 vaccines | 2020-06-17 | 1412.0 | 67.0 | view text |
| cord-343365-4y9fedcr | Chang, Christopher | Unmet Needs in Respiratory Diseases: “You Can’t Know Where You Are Going Until You Know Where You Have Been”—Anonymous | 2013-11-30 | 7295.0 | 407.0 | view text |
| cord-297131-3a9vjpvn | Charlton Hume, Hayley K. | Synthetic biology for bioengineering virus‐like particle vaccines | 2018-12-31 | nan | nan | view text |
| cord-289961-7q2wkwrf | Chattopadhyay, Saborni | Nanoparticle Vaccines Adopting Virus-like Features for Enhanced Immune Potentiation | 2017-06-09 | nan | nan | view text |
| cord-340042-intxyu46 | Chaudhry, Sundas Nasir | New insight on possible vaccine development against SARS-CoV-2 | 2020-09-11 | nan | nan | view text |
| cord-004348-4jdn4kw6 | Chen, Juine-Ruey | Better influenza vaccines: an industry perspective | 2020-02-14 | 6898.0 | 316.0 | view text |
| cord-305488-vk59ghjm | Choi, Kang-Seuk | Newcastle disease virus vectored vaccines as bivalent or antigen delivery vaccines | 2017-07-26 | nan | nan | view text |
| cord-278417-ty4wbtkv | Chugh, Tulsi | Timelines of COVID-19 Vaccines | 2020-07-21 | 1015.0 | 95.0 | view text |
| cord-322913-sq9mq6f1 | Ciabattini, Annalisa | Shelter from the cytokine storm: pitfalls and prospects in the development of SARS-CoV-2 vaccines for an elderly population | 2020-11-06 | 8068.0 | 363.0 | view text |
| cord-018677-gmitz3gg | Clemens, John D. | Sequential stages of clinical trials and overview of issues to be considered | 2005 | 6423.0 | 270.0 | view text |
| cord-017291-bhe34dky | Cohen, Cheryl | Influenza | 2017-05-05 | 7128.0 | 381.0 | view text |
| cord-303447-3a7jxl34 | Cohn, Amanda C. | Immunizations in the United States: A Rite of Passage | 2005-05-28 | nan | nan | view text |
| cord-349309-7xsbpid7 | Condit, Richard C | The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of viral vector vaccines | 2020-09-06 | 2058.0 | 98.0 | view text |
| cord-285760-y37ji92k | Connell, Anna R. | Mumps Outbreaks in Vaccinated Populations—Is It Time to Re-assess the Clinical Efficacy of Vaccines? | 2020-09-18 | nan | nan | view text |
| cord-326614-cik3ino6 | Corder, Brigette N. | A Decade in Review: A Systematic Review of Universal Influenza Vaccines in Clinical Trials during the 2010 Decade | 2020-10-20 | 7511.0 | 488.0 | view text |
| cord-003567-h8uq5z8b | Crank, Michelle C | Preparing for the Next Influenza Pandemic: The Development of a Universal Influenza Vaccine | 2019-04-15 | nan | nan | view text |
| cord-309555-1ksahg3o | Cresswell, E. | A questionnaire-based survey on the uptake and use of cattle vaccines in the UK | 2014-07-11 | 4279.0 | 211.0 | view text |
| cord-303674-0xo2fiop | Criscuolo, E. | Alternative Methods of Vaccine Delivery: An Overview of Edible and Intradermal Vaccines | 2019-03-04 | nan | nan | view text |
| cord-270998-1adloi3o | Cunha, Rafes D. S. | Comparison of immunity against canine distemper, adenovirus and parvovirus after vaccination with two multivalent canine vaccines | 2020-04-27 | 2424.0 | 125.0 | view text |
| cord-285128-48l1w65p | Custers, Jerome | Vaccines based on replication incompetent Ad26 viral vectors: standardized template with key considerations for a risk/benefit assessment | 2020-10-03 | nan | nan | view text |
| cord-275210-baqaqsli | DREESEN, DAVID W. | Animal Vaccines | 2007-09-05 | 5271.0 | 263.0 | view text |
| cord-016126-i7z0tdrk | Dangi, Mehak | Advanced In Silico Tools for Designing of Antigenic Epitope as Potential Vaccine Candidates Against Coronavirus | 2018-10-14 | 3221.0 | 197.0 | view text |
| cord-258626-p469ysi8 | Davis-Wurzler, Gina M. | 2013 Update on Current Vaccination Strategies in Puppies and Kittens | 2014-02-26 | 10938.0 | 543.0 | view text |
| cord-275538-c44gmu22 | Davis-Wurzler, Gina M. | Current Vaccination Strategies in Puppies and Kittens | 2006-03-24 | 10385.0 | 472.0 | view text |
| cord-009947-0zz4x8li | Day, M. J. | COMPILED BY THE VACCINATION GUIDELINES GROUP (VGG) OF THE WORLD SMALL ANIMAL VETERINARY ASSOCIATION (WSAVA) | 2007-09-03 | nan | nan | view text |
| cord-257582-e9306xae | Day, M. J. | Recommendations on vaccination for Latin American small animal practitioners: a report of the WSAVA Vaccination Guidelines Group | 2020-03-30 | 25474.0 | 1258.0 | view text |
| cord-342819-p8wp6yvo | De Groot, Anne S | Making vaccines “on demand”: A potential solution for emerging pathogens and biodefense? | 2013-09-01 | nan | nan | view text |
| cord-328698-eeg1k5a6 | Detoc, Maëlle | Intention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemic | 2020-09-17 | 2522.0 | 129.0 | view text |
| cord-287410-boxxlopy | Devi, Arpita | In silico designing of multi-epitope vaccine construct against human coronavirus infections | 2020-08-10 | 7189.0 | 446.0 | view text |
| cord-266199-smlq11y9 | Dhakal, Santosh | Nanoparticle-based vaccine development and evaluation against viral infections in pigs | 2019-11-06 | 7647.0 | 414.0 | view text |
| cord-269352-0o3mryu1 | Dhama, K. | DNA vaccines and their applications in veterinary practice: current perspectives | 2008-04-19 | 6856.0 | 339.0 | view text |
| cord-007733-zh8e76w7 | DiMenna, Lauren J. | Pandemic Influenza Vaccines | 2009-06-15 | 12728.0 | 594.0 | view text |
| cord-311331-l7dehit8 | Diaz-Arévalo, Diana | Nanoparticle-based vaccines: opportunities and limitations | 2020-01-17 | nan | nan | view text |
| cord-324690-82qsirnk | Dieffenbach, Carl W | The search for an HIV vaccine, the journey continues | 2020-05-16 | 1469.0 | 73.0 | view text |
| cord-353730-owcapg8h | Dietrich, Jes | Inducing Dose Sparing with Inactivated Polio Virus Formulated in Adjuvant CAF01 | 2014-06-23 | nan | nan | view text |
| cord-260956-w6wxsg4p | Dimitrov, Kiril M. | Newcastle disease vaccines—A solved problem or a continuous challenge? | 2017-07-31 | 10563.0 | 423.0 | view text |
| cord-305175-1wg0wodr | Dolzhikova, I. V. | Preclinical Studies of Immunogenity, Protectivity, and Safety of the Combined Vector Vaccine for Prevention of the Middle East Respiratory Syndrome | 2020 | nan | nan | view text |
| cord-006892-n2ncamqh | Donaldson, Braeden | Virus-like particle vaccines: immunology and formulation for clinical translation | 2018-09-19 | nan | nan | view text |
| cord-354030-8tfg881h | Dong, Rong | Contriving Multi-Epitope Subunit of Vaccine for COVID-19: Immunoinformatics Approaches | 2020-07-28 | nan | nan | view text |
| cord-021637-f5wwn45z | Douglas, R. Gordon | The Vaccine Industry | 2017-07-17 | 6455.0 | 302.0 | view text |
| cord-324911-6s7ubbxl | Drury, Georgina | Process mapping of vaccines: Understanding the limitations in current response to emerging epidemic threats | 2019-04-17 | nan | nan | view text |
| cord-294108-uvnh0s9r | Dube, Taru | Repurposed Drugs, Molecular Vaccines, Immune‐Modulators, and Nanotherapeutics to Treat and Prevent COVID‐19 Associated with SARS‐CoV‐2, a Deadly Nanovector | 2020-10-25 | nan | nan | view text |
| cord-017838-fbotc479 | Fagone, Paolo | Electroporation-Mediated DNA Vaccination | 2010-12-15 | nan | nan | view text |
| cord-285691-pceenwb6 | Falo, Louis D. | Advances in skin science enable the development of a COVID-19 Vaccine | 2020-05-30 | 180.0 | 17.0 | view text |
| cord-336730-hqgwj8vs | Fehr, Daniela | Placebo-controlled evaluation of a modified life virus vaccine against feline infectious peritonitis: safety and efficacy under field conditions | 1997-07-31 | 4307.0 | 230.0 | view text |
| cord-326960-9phlylce | Felberbaum, Rachael S. | The baculovirus expression vector system: A commercial manufacturing platform for viral vaccines and gene therapy vectors | 2015-03-20 | nan | nan | view text |
| cord-305807-n3fs7533 | Ferreira, T B | Use of adenoviral vectors as veterinary vaccines | 2005-10-18 | 8466.0 | 437.0 | view text |
| cord-289763-jek2pd31 | Fisher, Kimberly A. | Attitudes Toward a Potential SARS-CoV-2 Vaccine: A Survey of U.S. Adults | 2020-09-04 | nan | nan | view text |
| cord-264814-v4wnmg03 | Flanagan, Katie L. | Progress and Pitfalls in the Quest for Effective SARS-CoV-2 (COVID-19) Vaccines | 2020-10-02 | 15130.0 | 700.0 | view text |
| cord-339091-3xk2w0d2 | Flower, Darren R | Computer aided selection of candidate vaccine antigens | 2010-11-03 | nan | nan | view text |
| cord-016594-lj0us1dq | Flower, Darren R. | Identification of Candidate Vaccine Antigens In Silico | 2012-09-28 | 12570.0 | 653.0 | view text |
| cord-017841-57rm046y | Flower, Darren R. | Immunomic Discovery of Adjuvants, Delivery Systems, and Candidate Subunit Vaccines: A Brief Introduction | 2012-09-28 | 4995.0 | 230.0 | view text |
| cord-319226-yvgvyif0 | French, Jeff | Key Guidelines in Developing a Pre-Emptive COVID-19 Vaccination Uptake Promotion Strategy | 2020-08-13 | nan | nan | view text |
| cord-354068-4qlk6y7h | Friedrich, Brian M. | Potential Vaccines and Post-Exposure Treatments for Filovirus Infections | 2012-09-21 | 10605.0 | 540.0 | view text |
| cord-316534-ep7ezoko | Gamble, Lena J | Current progress in the development of a prophylactic vaccine for HIV-1 | 2010-12-22 | nan | nan | view text |
| cord-323540-7b2mt1a8 | García, Leidy Y. | Contingent assessment of the COVID-19 vaccine | 2020-06-25 | nan | nan | view text |
| cord-296469-h0ma163u | Gellin, Bruce G. | Preparing for the unpredictable: The continuing need for pandemic influenza preparedness | 2016-10-26 | 1501.0 | 78.0 | view text |
| cord-276907-b855tj7x | Giersing, Birgitte K. | Report from the World Health Organization’s third Product Development for Vaccines Advisory Committee (PDVAC) meeting, Geneva, 8–10th June 2016 | 2019-11-28 | 12249.0 | 457.0 | view text |
| cord-018969-0zrnfaad | Giese, Matthias | Types of Recombinant Vaccines | 2015-09-24 | 14221.0 | 811.0 | view text |
| cord-315570-khm1veuv | González-Mora, Alejandro | Bacteriophage-Based Vaccines: A Potent Approach for Antigen Delivery | 2020-09-04 | nan | nan | view text |
| cord-016713-pw4f8asc | Goyal, Amit K. | Nanotechnological Approaches for Genetic Immunization | 2013-05-24 | 16034.0 | 814.0 | view text |
| cord-007710-0u5ot5h4 | Graham, Barney S. | Challenges and Opportunities for Respiratory Syncytial Virus Vaccines | 2013-05-24 | 4113.0 | 161.0 | view text |
| cord-325141-x3txhjkr | Grech, Victor | Vaccine hesitancy among Maltese Healthcare workers toward influenza and novel COVID-19 vaccination | 2020-10-01 | 3681.0 | 234.0 | view text |
| cord-318683-1yxurnev | Green, Manfred S | Confronting the threat of bioterrorism: realities, challenges, and defensive strategies | 2018-10-16 | nan | nan | view text |
| cord-337577-dqikrmk7 | Greenberg, Harry B. | Vaccination against Viruses | 2016-05-09 | 4789.0 | 225.0 | view text |
| cord-006252-cbelsymu | Gross, Peter A. | Current Recommendations for the Prevention and Treatment of Influenza in the Older Population | 2012-11-18 | nan | nan | view text |
| cord-022039-y0l943xg | Gruber, Marion F. | Regulation and Testing of Vaccines | 2017-07-17 | 14882.0 | 585.0 | view text |
| cord-013290-j3assowx | Guibinga, Ghiabe H. | Protection against Borreliella burgdorferi infection mediated by a synthetically engineered DNA vaccine | 2020-08-12 | nan | nan | view text |
| cord-265472-b1s4stvz | Guimarães, Luísa Eça | Vaccines, adjuvants and autoimmunity | 2015-10-31 | 14633.0 | 821.0 | view text |
| cord-263277-m4too6ob | Guzmán, Carlos Alberto | Next Generation Influenza Vaccines: Looking into the Crystal Ball | 2020-08-21 | 1921.0 | 102.0 | view text |
| cord-351649-87g7g5au | Haagmans, Bart L. | SARS | 2009-01-30 | nan | nan | view text |
| cord-343347-guciupc8 | Hajj Hussein, Inaya | Vaccines Through Centuries: Major Cornerstones of Global Health | 2015-11-26 | nan | nan | view text |
| cord-315131-4yb2b70g | Hammerschmidt, Sven | Threat of infection: Microbes of high pathogenic potential – strategies for detection, control and eradication | 2005-06-28 | nan | nan | view text |
| cord-013326-qsqaimsy | Hankaniemi, Minna M. | Structural Insight into CVB3-VLP Non-Adjuvanted Vaccine | 2020-08-24 | nan | nan | view text |
| cord-000194-cwzpb8fu | Haque, Azizul | Confronting Potential Influenza A (H5N1) Pandemic with Better Vaccines | 2007-10-17 | 5237.0 | 257.0 | view text |
| cord-270709-jahnjvyk | Hasford, Joerg | Large Simple Double-Blind Randomized Trials for the Rapid Assessment of the Effectiveness of COVID-19 Vaccines | 2020-08-26 | 966.0 | 51.0 | view text |
| cord-032751-pmclolvh | Head, Katharine J. | A National Survey Assessing SARS-CoV-2 Vaccination Intentions: Implications for Future Public Health Communication Efforts | 2020-09-23 | 5086.0 | 305.0 | view text |
| cord-254890-4ynsgu6c | Heldens, J.G.M. | Veterinary vaccine development from an industrial perspective | 2008-03-03 | 9217.0 | 443.0 | view text |
| cord-257533-i85dyg8n | Henn, Wolfram | Allocation criteria for an initial shortage of a future SARS-CoV-2 vaccine and necessary measures for global immunity | 2020-06-23 | 1070.0 | 60.0 | view text |
| cord-016903-z2vqfq98 | Herndler-Brandstetter, Dietmar | The Efficacy of Vaccines to Prevent Infectious Diseases in the Elderly | 2007 | nan | nan | view text |
| cord-344669-hw57silv | Hilton, Shona | Newsprint media representations of the introduction of the HPV vaccination programme for cervical cancer prevention in the UK (2005–2008) | 2010-03-17 | nan | nan | view text |
| cord-328935-mn8r972x | Hodgins, Douglas C. | Mucosal Veterinary Vaccines: Comparative Vaccinology | 2015-03-13 | 16336.0 | 785.0 | view text |
| cord-343421-k1dqe4lk | Hoelzer, Karin | Vaccines as alternatives to antibiotics for food producing animals. Part 2: new approaches and potential solutions | 2018-07-31 | nan | nan | view text |
| cord-355689-mo4mvwch | Huang, Jiechen | Role of vaccine efficacy in the vaccination behavior under myopic update rule on complex networks | 2019-09-06 | nan | nan | view text |
| cord-275031-0y0d4brz | Häfner, Sophia | Contagion 2.0() | 2015-07-02 | 1984.0 | 89.0 | view text |
| cord-018040-k0h5ejjt | Ilyinskii, P. | Aspects of Microparticle Utilization for Potentiation of Novel Vaccines: Promises and Risks | 2009 | nan | nan | view text |
| cord-289360-h6wvx7gw | Imperiale, Michael J. | The Importance of Virology at a Time of Great Need and Great Jeopardy | 2015-03-10 | 1290.0 | 59.0 | view text |
| cord-264356-3zu4w0a9 | Ino, Hiroyasu | Vaccine mandate in long‐term care facilities | 2020-10-01 | 1548.0 | 107.0 | view text |
| cord-004274-cot05vx7 | Jackson, Nicholas A. C. | The promise of mRNA vaccines: a biotech and industrial perspective | 2020-02-04 | 4253.0 | 251.0 | view text |
| cord-339726-eg0hajzl | Jamrozik, Euzebiusz | Coronavirus Human Infection Challenge Studies: Assessing Potential Benefits and Risks | 2020-08-25 | 3643.0 | 154.0 | view text |
| cord-330342-i55czo8a | Johnson, Alton R. | In Pursuit of a SARS-CoV-2 Vaccine | 2020-10-28 | 1116.0 | 48.0 | view text |
| cord-002282-ldfa616a | Joung, Young Hee | The Last Ten Years of Advancements in Plant-Derived Recombinant Vaccines against Hepatitis B | 2016-10-13 | 8136.0 | 449.0 | view text |
| cord-301876-d2j9wpqk | Kalita, Parismita | Design of a peptide-based subunit vaccine against novel coronavirus SARS-CoV-2 | 2020-05-04 | 3449.0 | 212.0 | view text |
| cord-261876-7rsc803x | Kaslow, David C. | Certainty of success: three critical parameters in coronavirus vaccine development | 2020-05-25 | 6462.0 | 305.0 | view text |
| cord-322955-7dw32xby | Kathwate, Gunderao H | In Silico design and characterization of multi-epitopes vaccine for SARS-CoV2 from its spike proteins | 2020-06-12 | nan | nan | view text |
| cord-313911-lfn9ggg3 | Kenner, Julie | LC16m8: An attenuated smallpox vaccine | 2006-11-17 | 7952.0 | 377.0 | view text |
| cord-324349-26uuczmi | Kidokoro, Minoru | Vaccinia Virus LC16m8∆ as a Vaccine Vector for Clinical Applications | 2014-10-17 | nan | nan | view text |
| cord-294347-axkdf5vu | Kim, Shin-Hee | Newcastle Disease Virus as a Vaccine Vector for Development of Human and Veterinary Vaccines | 2016-07-04 | nan | nan | view text |
| cord-000452-1gd006zy | Kim, Y. C. | Delivery Systems for Intradermal Vaccination | 2011-04-07 | nan | nan | view text |
| cord-005081-kxrzv16n | Kiselev, O. I. | Progress in the development of pandemic influenza vaccines and their production technologies | 2010-11-12 | 7263.0 | 340.0 | view text |
| cord-324001-m7ys95z7 | Kobinger, Gary P. | Assessment of the Efficacy of Commercially Available and Candidate Vaccines against a Pandemic H1N1 2009 Virus | 2010-04-01 | nan | nan | view text |
| cord-007440-7gcpk9x9 | Koprowski, Hilary | Vaccines and sera through plant biotechnology() | 2005-03-07 | 2110.0 | 129.0 | view text |
| cord-289599-7vsynfgn | Kostoff, Ronald N. | COVID-19 vaccine safety | 2020-09-18 | 2715.0 | 153.0 | view text |
| cord-285883-rlliacex | Kremer, Eric J. | Pros and Cons of Adenovirus-Based SARS-CoV-2 Vaccines | 2020-10-09 | 1486.0 | 83.0 | view text |
| cord-272241-2fwz8z8n | Kumar, Amit | Exploring the SARS-CoV-2 structural proteins for multi-epitope vaccine development: an in-silico approach | 2020-09-09 | 4608.0 | 281.0 | view text |
| cord-345689-5ns1onkw | Kusters, Inca C. | Manufacturing Vaccines for an Emerging Viral Infection–Specific Issues Associated with the Development of a Prototype SARS Vaccine | 2009-01-30 | nan | nan | view text |
| cord-273151-1h8c4yq9 | LOCHT, Camille | Vaccines against COVID-19 | 2020-10-20 | 1516.0 | 94.0 | view text |
| cord-282507-swxs5pr1 | Lacaille-Dubois, Marie-Aleth | Updated insights into the mechanism of action and clinical profile of the immunoadjuvant QS-21: A review | 2019-07-31 | 8445.0 | 355.0 | view text |
| cord-002500-9p2n8tjx | Lambe, Teresa | A review of Phase I trials of Ebola virus vaccines: what can we learn from the race to develop novel vaccines? | 2017-05-26 | 7327.0 | 288.0 | view text |
| cord-294856-eeh2a0t8 | Lambert, Paul-Henri | Consensus Summary Report for CEPI/BC March 12-13, 2020 Meeting: Assessment of Risk of Disease Enhancement with COVID-19 Vaccines | 2020-05-25 | 5236.0 | 251.0 | view text |
| cord-332358-0t4uxmj2 | Lamphear, Barry J. | A corn-based delivery system for animal vaccines: an oral transmissible gastroenteritis virus vaccine boosts lactogenic immunity in swine | 2004-06-23 | 3131.0 | 136.0 | view text |
| cord-301577-3qc56c7d | Lamson, Daryl M. | An unusual case of influenza-like illness after yellow fever vaccination | 2014-05-31 | nan | nan | view text |
| cord-292528-8kdhf123 | Lau, Yuk-Fai | A TLR3 ligand that exhibits potent inhibition of influenza virus replication and has strong adjuvant activity has the potential for dual applications in an influenza pandemic | 2009-02-25 | nan | nan | view text |
| cord-302268-dmb0293x | Lee, Sujin | Recent Advances of Vaccine Adjuvants for Infectious Diseases | 2015-04-23 | 3731.0 | 224.0 | view text |
| cord-257027-q2y7fewk | Lemaire, D. | Coping with genetic diversity: the contribution of pathogen and human genomics to modern vaccinology | 2011-10-28 | 5844.0 | 241.0 | view text |
| cord-011486-5osu6hdu | Lestari, Fajar Budi | Rotavirus infection in children in Southeast Asia 2008–2018: disease burden, genotype distribution, seasonality, and vaccination | 2020-05-21 | 7558.0 | 399.0 | view text |
| cord-000262-4owsb0bg | Leung, Gabriel M. | Reflections on Pandemic (H1N1) 2009 and the International Response | 2010-10-05 | 4616.0 | 244.0 | view text |
| cord-350565-mejd7blb | Lewnard, Joseph A | Emerging Challenges and Opportunities in Infectious Disease Epidemiology | 2019-03-16 | 6614.0 | 289.0 | view text |
| cord-267897-w4pbq2lb | Lindblad, E. B. | Chapter 18 Mineral Adjuvants ∗ ∗ The present chapter is an updated version of the chapter “Mineral Adjuvants,” published in Immunopotentiators in Modern Vaccines, p. 217–233. Ed. Virgil Schijns & Derek O''Hagan, Elsevier Science Publishers (2005). | 2017-12-31 | 9771.0 | 501.0 | view text |
| cord-022168-qautse9a | Liu, Li | Clinical Use of DNA Vaccines | 2017-07-25 | 7120.0 | 321.0 | view text |
| cord-291315-y40s45iv | Logunov, Denis Y | Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia | 2020-09-04 | nan | nan | view text |
| cord-344162-8gbe6qo7 | Loomba, S. | Measuring the Impact of Exposure to COVID-19 Vaccine Misinformation on Vaccine Intent in the UK and US | 2020-10-26 | nan | nan | view text |
| cord-348144-t0chpsuh | Lucas, Alexander H. | Carbohydrate Moieties as Vaccine Candidates | 2005-09-01 | nan | nan | view text |
| cord-005246-cskb0njm | Ludwig, George V. | Insect-transmitted vertebrate viruses: Flaviviridae | 1993 | nan | nan | view text |
| cord-335960-biwnqa3f | Luke, Anthony | Prevention of Infectious Diseases in Athletes | 2007-07-31 | 6813.0 | 373.0 | view text |
| cord-279260-tdvb0fhv | Lv, Huibin | COVID‐19 vaccines: knowing the unknown | 2020-05-21 | 1476.0 | 98.0 | view text |
| cord-002333-90f9vr0a | Madan, Anuradha | Immunogenicity and Safety of an AS03-Adjuvanted H7N9 Pandemic Influenza Vaccine in a Randomized Trial in Healthy Adults | 2016-12-01 | 4250.0 | 210.0 | view text |
| cord-290004-v3ruj5bq | Madsen, Anders | Prospects and Challenges in the Development of Universal Influenza Vaccines | 2020-07-06 | nan | nan | view text |
| cord-323794-p3zjxo1h | Malik, A. A. | Determinants of COVID-19 Vaccine Acceptance in the U.S. | 2020-05-24 | 3678.0 | 210.0 | view text |
| cord-316893-jwjr67po | Mantel, Carsten | New immunization strategies: adapting to global challenges | 2019-12-04 | nan | nan | view text |
| cord-354972-nc496v6s | Margolin, Emmanuel | Prospects for SARS-CoV-2 diagnostics, therapeutics and vaccines in Africa | 2020-09-10 | 10919.0 | 464.0 | view text |
| cord-003926-ycdaw2vh | Maslow, Joel N. | Zika Vaccine Development—Current Progress and Challenges for the Future | 2019-07-14 | 3766.0 | 189.0 | view text |
| cord-303368-tzgql225 | Masset, N. | Effectiveness of two intranasal vaccines for the control of bovine respiratory disease in newborn beef calves: A randomized non-inferiority multicentre field trial | 2020-08-19 | nan | nan | view text |
| cord-296831-wdpatr2z | Matoo, Javaid Jeelani | Resiquimod enhances mucosal and systemic immunity against avian infectious bronchitis virus vaccine in the chicken | 2018-04-07 | 5017.0 | 291.0 | view text |
| cord-355618-7kfxc2w1 | McAteer, John | The VACCINES Act, Deciphering Vaccine Hesitancy in the Time of COVID19 | 2020-04-13 | 1893.0 | 106.0 | view text |
| cord-302155-hksmt48i | McLean, Rebecca K. | Vaccine Development for Nipah Virus Infection in Pigs | 2019-02-04 | nan | nan | view text |
| cord-261301-8mw2kpmr | McVey, Scott | Vaccines in Veterinary Medicine: A Brief Review of History and Technology | 2010-05-13 | 4039.0 | 233.0 | view text |
| cord-004078-d1pd09zj | Mettu, Ravinder | Synthetic carbohydrate-based vaccines: challenges and opportunities | 2020-01-03 | 11531.0 | 567.0 | view text |
| cord-018165-afzjx2ci | Modrow, Susanne | Vaccines | 2013-08-12 | nan | nan | view text |
| cord-302222-9ad0fw6z | Monath, Thomas P. | Vaccines against diseases transmitted from animals to humans: A one health paradigm | 2013-11-04 | nan | nan | view text |
| cord-304188-1nm1tbig | Moody, M. Anthony | Modulation of HIV-1 immunity by adjuvants | 2014-04-10 | nan | nan | view text |
| cord-340516-9dfaqsv7 | Moore, Anne C. | Pre-clinical studies of a recombinant adenoviral mucosal vaccine to prevent SARS-CoV-2 infection | 2020-09-06 | 6679.0 | 335.0 | view text |
| cord-285982-1a5u7uux | Moss, Ronald B | Prospects for control of emerging infectious diseases with plasmid DNA vaccines | 2009-09-07 | nan | nan | view text |
| cord-263619-p17oomzn | Moss, William J. | Measles | 2009-01-30 | 9541.0 | 457.0 | view text |
| cord-261566-fn08b0y2 | Mudgal, Rajat | Prospects for mucosal vaccine: shutting the door on SARS-CoV-2 | 2020-09-15 | 7060.0 | 413.0 | view text |
| cord-331217-uup16bhm | Murphy, Frederick A. | Adventitious Agents and Smallpox Vaccine in Strategic National Stockpile | 2005-07-17 | 2282.0 | 105.0 | view text |
| cord-273099-zkk5d6gd | Muzumdar, Jagannath M. | Vaccine supply, demand, and policy: A primer | 2016-01-01 | 7496.0 | 466.0 | view text |
| cord-323710-cmbg0ty8 | Mühlebach, Michael D. | Development of Recombinant Measles Virus-Based Vaccines | 2016-11-26 | nan | nan | view text |
| cord-027654-k0uby99n | Nabel, Gary J. | The development of gene-based vectors for immunization | 2020-06-22 | 6550.0 | 321.0 | view text |
| cord-348283-7xorq5ce | Naz, Anam | Designing Multi-Epitope Vaccines to Combat Emerging Coronavirus Disease 2019 (COVID-19) by Employing Immuno-Informatics Approach | 2020-07-10 | nan | nan | view text |
| cord-279629-t1xjy12y | Nazneen Akhand, Mst Rubaiat | Genome based Evolutionary study of SARS-CoV-2 towards the Prediction of Epitope Based Chimeric Vaccine | 2020-04-15 | 6717.0 | 379.0 | view text |
| cord-355906-yeaw9nr8 | Nedjadi, Taoufik | Tackling dengue fever: Current status and challenges | 2015-12-09 | nan | nan | view text |
| cord-344750-b9tndbg1 | Neumann-Böhme, Sebastian | Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19 | 2020-06-26 | nan | nan | view text |
| cord-344563-bjuvxpkc | Neustroev, M. P. | Developmental Results of a Vaccine against Salmonella-Induced Equine Abortion | 2020-11-04 | 2389.0 | 169.0 | view text |
| cord-269623-9pxdeva3 | Nicholson, Karl G | Influenza | 2003-11-22 | 9797.0 | 506.0 | view text |
| cord-008881-579ronfq | Nicholson, KarlG | MULTISITE INTRADERMAL ANTIRABIES VACCINATION: Immune Responses in Man and Protection of Rabbits Against Death from Street Virus by Postexposure Administration of Human Diploid-Cell-Strain Rabies Vaccine | 1981-10-24 | 2885.0 | 141.0 | view text |
| cord-025366-haf542y0 | Offit, Paul A. | Vaccine safety | 2012-11-07 | 16621.0 | 797.0 | view text |
| cord-004435-l66ost6q | Oli, Angus Nnamdi | Immunoinformatics and Vaccine Development: An Overview | 2020-02-26 | nan | nan | view text |
| cord-018811-zhwr3h07 | Oxford, John | Influenza Vaccines Have a Short but Illustrious History of Dedicated Science Enabling the Rapid Global Production of A/Swine (H1N1) Vaccine in the Current Pandemic | 2010-06-18 | 13247.0 | 618.0 | view text |
| cord-252856-oc0zd11h | Pagliusi, Sonia | Quality vaccines for all people(): Report on the 16th annual general meeting of the Developing Countries Vaccine Manufacturers'' Network, 05–07th October 2015, Bangkok, Thailand | 2016-06-30 | 4469.0 | 223.0 | view text |
| cord-255549-i2o6rs29 | Pagliusi, Sonia | Vaccines: Shaping global health() | 2017-03-14 | 4357.0 | 255.0 | view text |
| cord-268501-z4oztgi0 | Palatnik-de-Sousa, Clarisa B. | What Would Jenner and Pasteur Have Done About COVID-19 Coronavirus? The Urges of a Vaccinologist | 2020-08-26 | 6331.0 | 280.0 | view text |
| cord-002842-4evbeijx | Pandey, Rajan Kumar | Novel Immunoinformatics Approaches to Design Multi-epitope Subunit Vaccine for Malaria by Investigating Anopheles Salivary Protein | 2018-01-18 | 5768.0 | 311.0 | view text |
| cord-259927-xh9cw9ao | Papadopoulos, Nikolaos G. | Promising approaches for the treatment and prevention of viral respiratory illnesses | 2017-07-21 | 7342.0 | 400.0 | view text |
| cord-296998-ep46lzeo | Pawelec, Graham | Recent advances in influenza vaccines | 2020-04-28 | nan | nan | view text |
| cord-014901-d9szap94 | Permyakova, N. V. | State of research in the field of the creation of plant vaccines for veterinary use | 2015-01-04 | nan | nan | view text |
| cord-016371-zkawdcac | Perrie, Yvonne | Vaccines | 2013-10-17 | nan | nan | view text |
| cord-290705-7xkt6u73 | Petrini, Stefano | Evaluation of Passive Immunity Induced by Immunisation Using Two Inactivated gE-deleted Marker Vaccines against Infectious Bovine Rhinotracheitis (IBR) in Calves | 2020-01-04 | 4291.0 | 210.0 | view text |
| cord-353911-hp6s6ebh | Petráš, Marek | Early immune response in mice immunized with a semi-split inactivated vaccine against SARS-CoV-2 containing S protein-free particles and subunit S protein | 2020-11-03 | 2119.0 | 134.0 | view text |
| cord-254513-7d10vd86 | Phillips, B. C. | Echo chambers as early warning signals of widespread vaccine refusal in social-epidemiological networks | 2020-10-20 | 6215.0 | 357.0 | view text |
| cord-016475-7ldxvbpz | Pleschka, Stephan | Anti-viral approaches against influenza viruses | 2006 | 17084.0 | 860.0 | view text |
| cord-266204-ipa017wz | Poland, G. A. | Personalized vaccinology: A review | 2018-08-28 | 7232.0 | 331.0 | view text |
| cord-276209-5999g9gp | Poland, Gregory A. | Tortoises, hares, and vaccines: A cautionary note for SARS-CoV-2 vaccine development | 2020-06-02 | 1607.0 | 105.0 | view text |
| cord-016508-39glgeft | Possas, Cristina | Vaccines: Biotechnology Market, Coverage, and Regulatory Challenges for Achieving Sustainable Development Goals | 2019-06-13 | 6596.0 | 275.0 | view text |
| cord-267012-45tre8rn | Premanand, Balraj | Baculovirus Surface Display of Immunogenic Proteins for Vaccine Development | 2018-05-31 | 11102.0 | 530.0 | view text |
| cord-271153-c0aw6jkz | Privor-Dumm, Lois | Archetype analysis of older adult immunization decision-making and implementation in 34 countries | 2020-05-27 | 7745.0 | 404.0 | view text |
| cord-293234-ouykx6g5 | Puig-Barberà, J. | Effectiveness of the 2010–2011 seasonal influenza vaccine in preventing confirmed influenza hospitalizations in adults: A case–case comparison, case-control study | 2012-08-24 | 4417.0 | 226.0 | view text |
| cord-004181-exbs3tz7 | Pumchan, Ansaya | Novel Chimeric Multiepitope Vaccine for Streptococcosis Disease in Nile Tilapia (Oreochromis niloticus Linn.) | 2020-01-17 | 5769.0 | 291.0 | view text |
| cord-309999-izdl0f2i | Qin, Ede | Immunogenicity and protective efficacy in monkeys of purified inactivated Vero-cell SARS vaccine | 2006-02-13 | 3944.0 | 205.0 | view text |
| cord-315293-kng4z4kf | Quesenberry, Katherine E. | Basic Approach to Veterinary Care of Ferrets | 2020-05-29 | nan | nan | view text |
| cord-016178-2ix6c0he | Rajan, V. | An Oral Vaccine for TGEV Immunization of Pigs | 2014-05-28 | 6053.0 | 291.0 | view text |
| cord-280459-y0tbvs3t | Ramvikas, M. | Nasal Vaccine Delivery | 2016-10-07 | 7333.0 | 450.0 | view text |
| cord-000050-tfcerilc | Rao, Srinivas | Multivalent HA DNA Vaccination Protects against Highly Pathogenic H5N1 Avian Influenza Infection in Chickens and Mice | 2008-06-18 | nan | nan | view text |
| cord-311112-cg7wqc0q | Rappuoli, Rino | Vaccines, emerging viruses, and how to avoid disaster | 2014-11-29 | nan | nan | view text |
| cord-293559-c78wcr8m | Rego, Gabriel N. A. | Current Clinical Trials Protocols and the Global Effort for Immunization against SARS-CoV-2 | 2020-08-25 | nan | nan | view text |
| cord-257722-7rmzaau4 | Rhee, Joon Haeng | Current and New Approaches for Mucosal Vaccine Delivery | 2019-10-25 | 14120.0 | 678.0 | view text |
| cord-302247-moor7dfc | Richards, James | Feline Vaccination Guidelines | 2001-05-31 | 4808.0 | 259.0 | view text |
| cord-290031-vffa1bu0 | Richmond, Heather | Seasonal influenza vaccination during a pandemic | 2020-07-31 | 1686.0 | 86.0 | view text |
| cord-343448-xhm97wy2 | Rinaldi, Andrea | RNA to the rescue: RNA is one of the most promising targets for drug development given its wide variety of uses | 2020-06-26 | 2934.0 | 167.0 | view text |
| cord-032017-h0cj4izx | Roach, E. Steve | Child Neglect by Any Other Name | 2020-09-17 | 2285.0 | 120.0 | view text |
| cord-321901-zpi7uis1 | Roberts, Anjeanette | Animal models and antibody assays for evaluating candidate SARS vaccines: Summary of a technical meeting 25–26 August 2005, London, UK | 2006-11-30 | 6600.0 | 311.0 | view text |
| cord-003403-ypefqm71 | Roberts, Christine C. | Assay Challenges for Emerging Infectious Diseases: The Zika Experience | 2018-10-02 | 4957.0 | 248.0 | view text |
| cord-306733-df36w6l7 | Rosales-Mendoza, Sergio | What Does Plant-Based Vaccine Technology Offer to the Fight against COVID-19? | 2020-04-14 | nan | nan | view text |
| cord-009381-q9s38fkh | Roth, James A. | Mechanistic Bases for Adverse Vaccine Reactions and Vaccine Failures | 2007-09-28 | 5956.0 | 309.0 | view text |
| cord-018018-2yyv8vuy | Rybicki, Ed | History and Promise of Plant-Made Vaccines for Animals | 2018-07-04 | 9127.0 | 314.0 | view text |
| cord-318983-rmvqf6s9 | SCHMIDT, HARALD | Vaccine Rationing and the Urgency of Social Justice in the Covid‐19 Response | 2020-05-28 | 2883.0 | 143.0 | view text |
| cord-016268-xcx1c0da | Sahai, Aastha | Plant Edible Vaccines: A Revolution in Vaccination | 2013-04-15 | 11291.0 | 593.0 | view text |
| cord-352088-9k01ej6l | Saiz, Juan-Carlos | Vaccines against RNA Viruses | 2020-08-27 | nan | nan | view text |
| cord-328557-f6o1aynz | Samad, Abdus | Designing a multi-epitope vaccine against SARS-CoV-2: an immunoinformatics approach | 2020-07-17 | nan | nan | view text |
| cord-280172-6o1gqe8v | Sanami, Samira | Design of a Multi-epitope Vaccine against SARS-CoV-2 using Immunoinformatics approach | 2020-07-15 | 5835.0 | 307.0 | view text |
| cord-267666-i7uuf3ck | Sarkar, Bishajit | Engineering a Novel Subunit Vaccine against SARS-CoV-2 by Exploring Immunoformatics Approach | 2020-11-11 | 1873.0 | 129.0 | view text |
| cord-271250-ywb26cq6 | Sarkar, Indranil | Selection of adjuvants for vaccines targeting specific pathogens | 2019-04-22 | 11394.0 | 542.0 | view text |
| cord-016200-zfh20im0 | Saxena, Jyoti | Edible Vaccines | 2013-10-22 | 7627.0 | 417.0 | view text |
| cord-008716-38sqkh9m | Schmidt, Alexander C | Current research on respiratory viral infections: Third International Symposium | 2001-06-01 | nan | nan | view text |
| cord-294789-07hto8qn | Schoch-Spana, Monica | The public’s role in COVID-19 vaccination: human-centered recommendations to enhance pandemic vaccine awareness, access, and acceptance in the United States | 2020-10-29 | nan | nan | view text |
| cord-007681-vhghhvnu | Schwartz, Benjamin | Prioritization of Pandemic Influenza Vaccine: Rationale and Strategy for Decision Making | 2009-06-15 | 5047.0 | 182.0 | view text |
| cord-282246-wyanwvxa | Sen, Adrish | Chapter 40 The Role of Innate Immunity in Regulating Rotavirus Replication, Pathogenesis, and Host Range Restriction and the Implications for Live Rotaviral Vaccine Development | 2020-12-31 | 7562.0 | 325.0 | view text |
| cord-262282-9xh51cd1 | Serwer, Philip | Optimizing Anti-Viral Vaccine Responses: Input from a Non-Specialist | 2020-05-15 | nan | nan | view text |
| cord-287853-cob7ur35 | Sharma, Vaneet Kumar | The expanding role of mass spectrometry in the field of vaccine development | 2018-05-31 | 3756.0 | 207.0 | view text |
| cord-021966-5m21bsrw | Shaw, Alan R. | Vaccines | 2009-05-15 | nan | nan | view text |
| cord-274264-s477tw3x | Shen, M. | Projected COVID-19 epidemic in the United States in the context of the effectiveness of a potential vaccine and implications for social distancing and face mask use | 2020-10-30 | 4120.0 | 221.0 | view text |
| cord-009383-ozx5u0t3 | Sheppard, Michael | Viral Vectors for Veterinary Vaccines | 2007-09-28 | nan | nan | view text |
| cord-272512-gevrlcvy | Shewen, P.E. | Challenges in mucosal vaccination of cattle | 2009-03-15 | 4849.0 | 205.0 | view text |
| cord-325966-0g7a9s5z | Shih, Hsin-I. | Fighting COVID-19: a quick review of diagnoses, therapies, and vaccines | 2020-05-30 | nan | nan | view text |
| cord-003764-141u6ax7 | Shrestha, Ashish C. | Cytolytic Perforin as an Adjuvant to Enhance the Immunogenicity of DNA Vaccines | 2019-04-30 | nan | nan | view text |
| cord-016222-dltsdqcm | Siegel, Frederic R. | Lessening the Impacts from Non-Tectonic (Natural) Hazards and Triggered Events | 2016-06-24 | nan | nan | view text |
| cord-349249-jwvz1ux2 | Singh, Gagandeep | A Minimally Replicative Vaccine Protects Vaccinated Piglets Against Challenge With the Porcine Epidemic Diarrhea Virus | 2019-10-22 | nan | nan | view text |
| cord-269992-ruf0vvz4 | Sohrab, Sayed Sartaj | An edible vaccine development for coronavirus disease 2019: the concept | 2020-07-31 | 2003.0 | 119.0 | view text |
| cord-032600-lldbjm77 | Soni, Dheeraj | The sixth revolution in pediatric vaccinology: immunoengineering and delivery systems | 2020-09-14 | 6655.0 | 388.0 | view text |
| cord-010266-elhgew3x | Spier, R.E. | Ethical aspects of vaccines and vaccination | 1998-12-02 | 5153.0 | 207.0 | view text |
| cord-302082-aaokc182 | Stanberry, Lawrence R. | Vaccines of the future | 2011-08-31 | nan | nan | view text |
| cord-348409-oxjd263z | Stern, Zachariah | The development of inovirus-associated vector vaccines using phage-display technologies | 2019-09-08 | 6043.0 | 315.0 | view text |
| cord-011325-r42hzazp | Stowe, Julia | Do Vaccines Trigger Neurological Diseases? Epidemiological Evaluation of Vaccination and Neurological Diseases Using Examples of Multiple Sclerosis, Guillain–Barré Syndrome and Narcolepsy | 2019-10-01 | 4770.0 | 191.0 | view text |
| cord-309083-ew9cwiw0 | Su, Hang | Cyprinid viral diseases and vaccine development | 2018-09-07 | 11167.0 | 585.0 | view text |
| cord-265642-7mu530yp | Syomin, B. V. | Virus-Like Particles as an Instrument of Vaccine Production | 2019-06-17 | 7107.0 | 325.0 | view text |
| cord-285613-hbd44euq | Søborg, Christian | Vaccines in a hurry | 2009-05-26 | 3804.0 | 161.0 | view text |
| cord-296967-qiil3gqk | Tatlow, Dean | A novel concept for treatment and vaccination against Covid‐19 with an inhaled chitosan‐coated DNA vaccine encoding a secreted spike protein portion | 2020-08-08 | 2262.0 | 143.0 | view text |
| cord-255734-038xu4hq | Taylor, Deborah R. | Obstacles and advances in SARS vaccine development | 2006-02-13 | 5334.0 | 263.0 | view text |
| cord-344576-upsc9cf8 | Taylor-Robinson, Andrew W | A vaccine effective against Zika virus is theoretically possible but may not be delivered anytime soon | 2016-07-05 | 2604.0 | 154.0 | view text |
| cord-279026-s3yx62u6 | Tizard, Ian R. | Adverse consequences of vaccination | 2020-07-10 | 6722.0 | 432.0 | view text |
| cord-330496-p3o6zkhf | Tizard, Ian R. | Feline vaccines | 2020-07-10 | 4980.0 | 316.0 | view text |
| cord-265757-8ces57rn | Tondella, M. L. | International Bordetella pertussis assay standardization and harmonization meeting report. Centers for Disease Control and Prevention, Atlanta, Georgia, United States, 19–20 July 2007 | 2009-02-05 | 11130.0 | 494.0 | view text |
| cord-035016-ipv8npdy | Torreele, Els | Business-as-Usual will not Deliver the COVID-19 Vaccines We Need | 2020-11-09 | 5574.0 | 203.0 | view text |
| cord-289535-srrfr1es | Tregoning, J. S. | Vaccines for COVID‐19 | 2020-10-18 | nan | nan | view text |
| cord-339152-wfakzb6w | Trovato, Maria | Viral Emerging Diseases: Challenges in Developing Vaccination Strategies | 2020-09-03 | 12000.0 | 540.0 | view text |
| cord-021937-p9vqpazu | Tsai, Theodore F. | Immunization in the Asia-Pacific Region | 2017-07-17 | 9479.0 | 392.0 | view text |
| cord-303880-zv4nbz9p | Tsikala Vafea, Maria | Emerging Technologies for Use in the Study, Diagnosis, and Treatment of Patients with COVID-19 | 2020-06-24 | nan | nan | view text |
| cord-325300-wawui0fd | Tulchinsky, Theodore H. | 4 Communicable Diseases | 2000-12-31 | 31276.0 | 1672.0 | view text |
| cord-325010-7qrht7uq | Van der Zeijst, Bernard A.M. | Infectious diseases know no borders: A plea for more collaboration between researchers in human and veterinary vaccines | 2008-04-11 | nan | nan | view text |
| cord-274756-nnm1n09a | Varadé, Jezabel | Human immunology and immunotherapy: main achievements and challenges | 2020-09-02 | nan | nan | view text |
| cord-283405-aozxvxxs | Vermillion, Meghan S. | Pregnancy and infection: using disease pathogenesis to inform vaccine strategy | 2018-02-01 | nan | nan | view text |
| cord-006890-81wv1s33 | Viret, Jean-Francois | Development of a SARS vaccine: an industrial perspective on the global race against a global disease | 2014-01-09 | nan | nan | view text |
| cord-276193-cngz535o | Volz, A. | Modified Vaccinia Virus Ankara: History, Value in Basic Research, and Current Perspectives for Vaccine Development | 2016-08-01 | nan | nan | view text |
| cord-288868-qfdxri93 | Wack, Andreas | Vaccinology at the beginning of the 21st century | 2005-06-13 | nan | nan | view text |
| cord-254469-7q6xi2xx | Wang, Fuzhou | An Evidence Based Perspective on mRNA-SARS-CoV-2 Vaccine Development | 2020-05-05 | 4737.0 | 245.0 | view text |
| cord-327650-6afsk8ix | Ward, Jeremy K. | The French public''s attitudes to a future COVID-19 vaccine: The politicization of a public health issue | 2020-10-06 | 4345.0 | 199.0 | view text |
| cord-274112-6t0wpiqy | Webby, RJ | Responsiveness to a pandemic alert: use of reverse genetics for rapid development of influenza vaccines | 2004-04-03 | 4199.0 | 206.0 | view text |
| cord-340900-f2iuy9e1 | Wehling, Martin | Calling for an exponential escalation scheme in vaccine development for COVID-19 | 2020-06-16 | 1032.0 | 55.0 | view text |
| cord-011370-as2v2c2h | Wilder-Smith, Annelies | Dengue vaccine development: status and future | 2019-11-29 | nan | nan | view text |
| cord-304472-mi5v6512 | Wilder-Smith, Annelies | Dengue vaccine development by the year 2020: challenges and prospects | 2020-10-18 | 4714.0 | 226.0 | view text |
| cord-258353-uw8padla | Williams, Joshua T.B. | Caring for the Vaccine Hesitant Family: Evidence-Based Alternatives to Dismissal | 2020-05-22 | 2765.0 | 182.0 | view text |
| cord-325052-7vlxa0i7 | Williamson, E. D. | Vaccines for emerging pathogens: prospects for licensure | 2019-04-11 | 6218.0 | 267.0 | view text |
| cord-003656-7mzsaz7a | Wium, Martha | DNA Vaccines Against Mycoplasma Elicit Humoral Immune Responses in Ostriches | 2019-05-14 | nan | nan | view text |
| cord-318593-ni84gzg5 | Wolf, Jayanthi | Applying lessons from the Ebola vaccine experience for SARS-CoV-2 and other epidemic pathogens | 2020-06-15 | 4094.0 | 187.0 | view text |
| cord-342831-4qfe8kok | Xia, Yufei | Chitosan-based mucosal adjuvants: Sunrise on the ocean | 2015-11-04 | 7863.0 | 380.0 | view text |
| cord-342800-62jklwiy | Xu, Shuqin | mRNA Vaccine Era—Mechanisms, Drug Platform and Clinical Prospection | 2020-09-09 | 13579.0 | 706.0 | view text |
| cord-296886-0bma2749 | Xu, Yingying | Intranasal DNA Vaccine for Protection against Respiratory Infectious Diseases: The Delivery Perspectives | 2014-07-10 | nan | nan | view text |
| cord-282158-08u3x1z4 | Yang, William H. | Long-term immunogenicity of an AS03-adjuvanted influenza A(H1N1)pdm09 vaccine in young and elderly adults: An observer-blind, randomized trial() | 2013-09-13 | 5295.0 | 252.0 | view text |
| cord-283475-28900qlr | Yu, Wenzhou | Vaccine-preventable disease control in the People’s Republic of China: 1949–2016 | 2018-12-18 | nan | nan | view text |
| cord-257899-l866puqk | Yun, Cheol-Heui | Nanoparticles to Improve the Efficacy of Vaccines | 2020-05-02 | 1843.0 | 82.0 | view text |
| cord-351190-sq6zsqqi | Zaheer, Tean | Topical Review On Nano-vaccinology: Biochemical Promises and Key Challenges | 2020-09-28 | nan | nan | view text |
| cord-282360-byqhzyzi | Zhang, Dingmei | Enterovirus 71 vaccine: close but still far | 2010-04-18 | 4404.0 | 248.0 | view text |
| cord-003828-bhfghcby | Zrzavy, Tobias | Vaccination in Multiple Sclerosis: Friend or Foe? | 2019-08-07 | nan | nan | view text |
| cord-014462-11ggaqf1 | nan | Abstracts of the Papers Presented in the XIX National Conference of Indian Virological Society, “Recent Trends in Viral Disease Problems and Management”, on 18–20 March, 2010, at S.V. University, Tirupati, Andhra Pradesh | 2011-04-21 | 35453.0 | 1711.0 | view text |